{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:47:27Z","timestamp":1790293647072,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T00:00:00Z","timestamp":1175212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,9,28]]},"DOI":"10.1007\/s10067-007-0614-1","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T18:16:20Z","timestamp":1175192180000},"page":"2001-2003","source":"Crossref","is-referenced-by-count":64,"title":["Cardiac sarcoidosis responding to monotherapy with infliximab"],"prefix":"10.1007","volume":"26","author":[{"given":"Imad","family":"Uthman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,30]]},"reference":[{"key":"614_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","volume":"83","author":"C Chapelon-Abric","year":"2004","unstructured":"Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL et al (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83:315\u2013334","journal-title":"Medicine (Baltimore)"},{"key":"614_CR2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1520\/JFS16209J","volume":"43","author":"JP Veinot","year":"1998","unstructured":"Veinot JP, Johnston B (1998) Cardiac sarcoidosis\u2014an occult cause of sudden death: a case report and literature review. J Forensic Sci 43:715\u2013717","journal-title":"J Forensic Sci"},{"key":"614_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1378\/chest.123.1.18","volume":"123","author":"OP Sharma","year":"2003","unstructured":"Sharma OP (2003) Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant art. Chest 123:18\u201319","journal-title":"Chest"},{"key":"614_CR4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11936-000-0034-x","volume":"2","author":"R Shabetai","year":"2000","unstructured":"Shabetai R (2000) Sarcoidosis and the heart. Curr Treat Options Cardiovasc Med 2:385\u2013398","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"614_CR5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204\u20131211","journal-title":"Circulation"},{"key":"614_CR6","first-page":"26","volume":"11","author":"K Iwai","year":"1994","unstructured":"Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26\u201331","journal-title":"Sarcoidosis"},{"key":"614_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1183\/09031936.96.09010047","volume":"9","author":"C Prior","year":"1996","unstructured":"Prior C, Knight RA, Herold M, Ott G, Spiteri MA (1996) Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J 9:47\u201353","journal-title":"Eur Respir J"},{"key":"614_CR8","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","volume":"168","author":"DR Roach","year":"2002","unstructured":"Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620\u20134627","journal-title":"J Immunol"},{"key":"614_CR9","first-page":"70","volume":"18","author":"RP Baughman","year":"2001","unstructured":"Baughman RP, Lower EE (2001) Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:70\u201374","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"614_CR10","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1002\/art.11357","volume":"48","author":"KU Ulbricht","year":"2003","unstructured":"Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE (2003) Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 48:3542\u20133543","journal-title":"Arthritis Rheum"},{"key":"614_CR11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.127.3.1064","volume":"127","author":"JD Doty","year":"2005","unstructured":"Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064\u20131071","journal-title":"Chest"},{"key":"614_CR12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.amjmed.2004.03.013","volume":"117","author":"JD Carter","year":"2004","unstructured":"Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med 117:277\u2013279","journal-title":"Am J Med"},{"key":"614_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-135-1-200107030-00010","volume":"135","author":"AM Yee","year":"2001","unstructured":"Yee AM, Pochapin MB (2001) Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27\u201331","journal-title":"Ann Intern Med"},{"key":"614_CR14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795\u2013802","journal-title":"Am J Respir Crit Care Med"},{"key":"614_CR15","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133\u20133140","journal-title":"Circulation"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0614-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0614-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0614-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:07Z","timestamp":1559119867000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0614-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,30]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,9,28]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0614-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,30]]}}}